Byooviz Euroopa Liit - eesti - EMA (European Medicines Agency)

byooviz

samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - oftalmoloogilised vahendid - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Tavneos Euroopa Liit - eesti - EMA (European Medicines Agency)

tavneos

vifor fresenius medical care renal pharma france - avacopan - microscopic polyangiitis; wegener granulomatosis - immunosupressandid - tavneos, in combination with a rituximab or cyclophosphamide regimen, is indicated for the treatment of adult patients with severe, active granulomatosis with polyangiitis (gpa) or microscopic polyangiitis (mpa).

Ximluci Euroopa Liit - eesti - EMA (European Medicines Agency)

ximluci

stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmoloogilised vahendid - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Ranivisio Euroopa Liit - eesti - EMA (European Medicines Agency)

ranivisio

midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmoloogilised vahendid - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).

Lumoxiti Euroopa Liit - eesti - EMA (European Medicines Agency)

lumoxiti

astrazeneca ab - moxetumomab pasudotox - leukeemia, karvane rakk - antineoplastilised ained - lumoxiti as monotherapy is indicated for the treatment of adult patients with relapsed or refractory hairy cell leukaemia (hcl) after receiving at least two prior systemic therapies, including treatment with a purine nucleoside analogue (pna).

GEMCITABINE ACCORD 100MG/ML infusioonilahuse kontsentraat Eesti - eesti - Ravimiamet

gemcitabine accord 100mg/ml infusioonilahuse kontsentraat

accord healthcare b.v. - gemtsitabiin - infusioonilahuse kontsentraat - 100mg 1ml 10ml 1tk; 100mg 1ml 15ml 1tk; 100mg 1ml 20ml 1tk

AGGRASTAT infusioonilahuse kontsentraat Eesti - eesti - Ravimiamet

aggrastat infusioonilahuse kontsentraat

correvio - tirofibaan - infusioonilahuse kontsentraat - 250mcg 1ml 50ml 1tk

TROMBOPRIV infusioonilahuse kontsentraat Eesti - eesti - Ravimiamet

trombopriv infusioonilahuse kontsentraat

uab „via pharma“ - tirofibaan - infusioonilahuse kontsentraat - 250mcg 1ml 50ml 1tk

GEMCITABINE KABI 40 MG/ML infusioonilahuse kontsentraat Eesti - eesti - Ravimiamet

gemcitabine kabi 40 mg/ml infusioonilahuse kontsentraat

fresenius kabi oncology plc - gemtsitabiin - infusioonilahuse kontsentraat - 40mg 1ml 50ml 1tk; 40mg 1ml 25ml 1tk; 40mg 1ml 5ml 1tk

VASONIT RETARD toimeainet prolongeeritult vabastav tablett Eesti - eesti - Ravimiamet

vasonit retard toimeainet prolongeeritult vabastav tablett

g.l. pharma gmbh - pentoksüfülliin - toimeainet prolongeeritult vabastav tablett - 600mg 50tk